LENSAR, Inc. (LNSR) News
Filter LNSR News Items
LNSR News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest LNSR News From Around the Web
Below are the latest news stories about LENSAR INC that investors may wish to consider to help them evaluate LNSR as an investment opportunity.
LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call TranscriptLENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning, and thank you for your participation. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Cameron Radinovic of Burns McClellan, Mr. Radinovic, please go ahead. Cameron Radinovic : Thank […] |
LENSAR Reports Third Quarter 2023 Results and Provides Business UpdateORLANDO, Fla., November 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives. |
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023ORLANDO, Fla., November 02, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2023 financial results will be released before market open on Thursday, November 9, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, November 9, 2023 to discuss the financial results and recent corpor |
A Piece Of The Puzzle Missing From LENSAR, Inc.'s (NASDAQ:LNSR) Share PriceWith a price-to-sales (or "P/S") ratio of 0.8x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending very bullish signals at the... |
Several Insiders Invested In LENSAR Flagging Positive NewsIt is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it... |
LENSAR Reports Second Quarter 2023 Results and Provides Business UpdateORLANDO, Fla., August 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2023 and provided an update on key operational initiatives. |
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology GroupsORLANDO, Fla., July 24, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that it has completed the installation of multiple ALLY Systems in five private equity-owned ("PE-owned") ophthalmology groups, including EyeSouth Partners’ network. EyeSouth Partners is one of the largest PE-owned ophthalmic focused, premier networks in the U.S., with 35 |
LENSAR Reports First Quarter 2023 Results and Provides Business UpdateORLANDO, Fla., May 15, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2023 and provided an update on key operational initiatives. |
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023ORLANDO, Fla., May 10, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s first quarter 2023 financial results will be released before market open on Monday, May 15, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Monday, May 15, 2023 to discuss the financial results and recent corporate high |
LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call TranscriptLENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a reminder, this conference call will be recorded. I would now like to turn the conference over […] |